Navigation Links
Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland

FREDERICK, Md., Oct. 2 /PRNewswire/ -- The Matan Companies has teamed up with Federal Capital Partners (FCP) to complete the financing for the development of the National Cancer Institute's 330,000 square foot Advanced Technology Research Facility (ATRF) at Riverside Research Park in Frederick, Maryland. The state-of-the art 200 million dollar office and laboratory facility will commence construction immediately and is slated for delivery in mid 2011. As part of the larger 177 acre Riverside Research Park, the National Cancer Institute's 62 acre campus will have expansion capacity for another 570,000 square feet, reserved for life-science and advanced technology partner organizations. "This site will be the center of an intensive new effort to bring together government, industry, academic, and nonprofit partners, working side-by-side, utilizing technological resources second to none, to more rapidly translate our latest genetic and molecular discoveries about cancer into effective new treatments that benefit patients," said John E. Niederhuber, M.D., director of the National Cancer Institute. With SAIC-Frederick, Inc. as its prime contractor, the new facility will be the only Federally Funded Research and Development Center (FFRDC) in the country focused exclusively on biomedical research and development, and concerted technology and R&D partnership efforts toward reducing the burden of cancer.

Matan and FCP partnered to secure the 52 million dollar construction financing from Wells Fargo Bank and US Bank. "Today's financing environment demands creative approaches to bring large, high profile projects like this to the market. The ATRF is one of the largest private biotech developments in the country to secure construction financing and it is a credit to everyone involved," stated Mark Matan, Principal of the Matan Companies. Matan Companies will develop and manage the project.

"We are incredibly excited to have formed this partnership with the Matan Companies to bring this very important project to fruition," said Esko Korhonen, Managing Partner of FCP. "The diligent work by our teams resulted in consummating a great financing package and we appreciated the opportunity to work with Wells Fargo, US Bank, Jones Lang LaSalle and Cassidy & Pinkard to get this deal completed."

Cassidy and Pinkard helped to secure the equity and debt for this transaction and Jones Lang LaSalle represented the Tenant.

About Riverside Research Park

Riverside Research Park is the first biomedical research and development park of its kind in Frederick Maryland. The 177 acre site has all necessary infrastructure and utilities in place and is ready to build. Riverside delivered its first tenant in the Spring of 2008, a 54,000 sf facility for Charles River Labs. Riverside can accommodate up to 1.8 million square feet of lab, R &D, and office space. "Frederick has a vibrant biotech community servicing NIH, the National Cancer Institute and Fort Detrick, but until now there hasn't been a destination for these companies to come together in a collaborative campus type environment in this market. Riverside Research Park provides just that and there has been a very high level of interest from companies looking to co-locate with the National Cancer Institute" said J.P. Matan, Director of Leasing for Matan Companies. Located within the city limits of Frederick and less than three miles from the main gates of Fort Detrick, Riverside is uniquely positioned to provide private sector companies, government agencies, and universities a secure and collaborative work environment. Abundant green space, water features, walk/jogging trails, courtyards, and chance meeting spaces will all add to the collaborative work environment and campus like feel of Riverside Research Park. For more information please visit:

About Federal Capital Partners

Founded in 1999 by partners Esko L. Korhonen and Lacy I. Rice, Federal Capital Partners (FCP) is a real estate investment and development company headquartered in Washington DC. Other partners include Alex Marshall and Tom Carr, former Chairman and CEO of CarrAmerica Realty Corp. who joined FCP as a partner in early 2007. Since its inception, FCP has acquired more than $1.2 billion of real estate assets consisting of multi-family, office, retail and industrial assets.

About Matan Companies

Headquartered in Frederick Maryland for over 30 years, Matan Companies is one of the regions premier commercial real estate and development firms. Matan's primary geographic focus is Frederick, Maryland and the I-270 Corridor. Matan's current portfolio consists of over 3.2 million square feet in 30 buildings with an additional 3 million square feet in the development pipeline.

About NCI-Frederick and SAIC-F

With SAIC-Frederick (SAIC-F) as its prime contractor, NCI-Frederick, is home to a cadre of researchers studying cancer and HIV/AIDS and is host to NCI's Advanced Technology Program, which encompasses nanotechnology, high-performance computing, genomics, and biomedical imaging, among other areas. SAIC-F, a wholly owned subsidiary of Science Applications International Corporation (SAIC), a Fortune 500(®) company (NYSE: SAI) - is the operations and technical support contractor for the National Cancer Institute's research and development center in Frederick, Md. "The NCI has identified an urgent need to convert basic research findings into effective cancer treatments that can be delivered to patients right away," said Larry O. Arthur, Ph.D., president of SAIC-Frederick. "The consolidation of our operations into modern facilities will enable us to do just that, with the specific goal of shortening timelines, reducing costs, and increasing productivity--all of which will benefit cancer patients and people at risk for cancer." More information about the NCI's Advanced Technology Partnerships Initiative (ATPI) can be found at

NCI at Riverside Research Park Building Rendering:

Photo Credit: CUH2A- Architect, Annapolis Web Publishing- Rendering

SOURCE Matan Companies

SOURCE Matan Companies
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards
2. Forbes Declares Prolifiq as One of Americas Most Promising Companies
3. Cadient Group Ranks on Inc. 5000 List of Fastest-Growing Companies for Third Consecutive Year
4. Precision Therapeutics Named to Inc. Magazines List of Fastest Growing Companies
5. Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies
6. PA Helping Life Science Companies Secure Venture Capital Needed to Expand, Gov. Rendell Says
7. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
8. SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies
9. Massachusetts Technology Corporation Named to Inc. 5000 List of Fastest Growing Private Companies
10. Sundia in Top 100 Fast-growth Outsourcing Companies in China
11. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
Post Your Comments:
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North Carolina, ... Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of the ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface ... detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
Breaking Biology News(10 mins):